What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Enzyme
Immunology, Cell biology, Immune system, B cell and T cell are her primary areas of study.
Her study connects Cytotoxic T cell and Immunology.
The Cell biology study combines topics in areas such as IL-2 receptor, Naive B cell, CD40, Antigen-presenting cell and Interleukin 21.
Her CD40 research includes themes of Interleukin 2 and Interleukin 12.
In her study, which falls under the umbrella issue of Immune system, Lymphotoxin, Tumor necrosis factor alpha, CXCL13, Chemokine and Spleen is strongly linked to Lymphatic system.
The study incorporates disciplines such as Cellular differentiation and Cytokine in addition to B cell.
Her most cited work include:
- Reciprocal regulation of polarized cytokine production by effector B and T cells. (688 citations)
- Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38 (648 citations)
- Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. (584 citations)
What are the main themes of her work throughout her whole career to date?
Frances E. Lund mainly focuses on Immunology, Cell biology, NAD+ kinase, B cell and Biochemistry.
Her Immunology study typically links adjacent topics like Cytotoxic T cell.
Her Cell biology research incorporates themes from Cell, T cell, IL-2 receptor, Antigen-presenting cell and CD40.
She interconnects Natural killer T cell and Interleukin 21 in the investigation of issues within Antigen-presenting cell.
Her biological study spans a wide range of topics, including Cytokine, Cellular differentiation, Virology, Molecular biology and Naive B cell.
Her Biochemistry study which covers ADP-ribosyl Cyclase that intersects with Cyclic ADP-ribose.
She most often published in these fields:
- Immunology (44.44%)
- Cell biology (35.80%)
- NAD+ kinase (16.67%)
What were the highlights of her more recent work (between 2017-2021)?
- Cell biology (35.80%)
- Immunology (44.44%)
- Effector (4.94%)
In recent papers she was focusing on the following fields of study:
Frances E. Lund spends much of her time researching Cell biology, Immunology, Effector, TLR7 and Immunity.
Her Cell biology study combines topics in areas such as Cell, Transcription factor, Chromatin, Priming and CXCR5.
Her studies deal with areas such as Interferon and Antibody-Secreting Cells, B cell as well as Chromatin.
Her Priming course of study focuses on Cell fate determination and Antigen and T cell.
Her study in Lung extends to Immunology with its themes.
Her TLR7 research focuses on Autoimmunity and how it connects with Naive B cell, CCL2, Molecular biology and Programmed cell death.
Between 2017 and 2021, her most popular works were:
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus (188 citations)
- The establishment of resident memory B cells in the lung requires local antigen encounter (80 citations)
- Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy. (37 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Enzyme
The scientist’s investigation covers issues in Cell biology, Cell, Transcription factor, Chromatin and Autoimmunity.
She has researched Cell biology in several fields, including In vitro, Downregulation and upregulation and Immunoglobulin secretion.
In the field of Cell, her study on Cell therapy overlaps with subjects such as Human Induced Pluripotent Stem Cells.
Her Transcription factor study integrates concerns from other disciplines, such as Reprogramming, Interferon and B cell.
Her Chromatin study incorporates themes from Antibody-Secreting Cells and Effector.
Her biological study deals with issues like Naive B cell, which deal with fields such as CXCR5 and Toll-like receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
